Primär- und Rezidivtherapie des Ovarialkarzinoms |
| |
Authors: | Dr. P. Harter S. Aebi F. Hilpert A. du Bois |
| |
Affiliation: | 1. Klinik für Gyn?kologie & Gyn?kologische Onkologie, HSK, Dr. Horst Schmidt Klinik, Ludwig-Erhard-Stra?e 100, 65199, Wiesbaden, Deutschland 2. Brust- und Tumorzentrum, Universit?tskliniken für Frauenheilkunde und Medizinische Onkologie, Inselspital Bern, Bern, Schweiz 3. Klinik für Gyn?kologie und Geburtshilfe, Universit?tsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Deutschland
|
| |
Abstract: | In most cases, ovarian cancer is diagnosed at an advanced stage because effective screening procedures are lacking. After adequate surgery and chemotherapy, cure is often possible in early ovarian cancer. In advanced ovarian cancer, most patients will relapse despite maximum surgery and chemotherapy. Combination chemotherapy has no advantage compared with monotherapy in so-called platinum-refractory ovarian cancer. In platinum-sensitive recurrent ovarian cancer, secondary surgery with the aim of complete resection could be beneficial in selected patients. Platinum-based combination chemotherapies are superior to monotherapy in such patients. Different toxicity profiles must be considered. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|